🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(5391)
All (5391)
Buys (527)
Sells (4864)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Cullinan Therapeutics, Inc.
(CGEM)
Fenton Mary Kay
— Chief Financial Officer
Feb 20, 2026
Sale
Shares
4,398
Price
$13.62
Total Value
$59.90K
Shares Held After
126,380
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cullinan Therapeutics, Inc.
(CGEM)
SUMER JACQUELYN L
— Chief Legal Officer
Feb 20, 2026
Sale
Shares
3,742
Price
$13.62
Total Value
$50.97K
Shares Held After
131,690
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Feb 20, 2026
Sale
Shares
397
Price
$51.96
Total Value
$20.63K
Shares Held After
22,600
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Feb 20, 2026
Sale
Shares
6,643
Price
$51.38
Total Value
$341.34K
Shares Held After
22,997
% of Holdings
22.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ACCURAY INC
(ARAY)
MAYER STEVEN F
— Director
Feb 20, 2026
Purchase
Shares
54,875
Price
$0.56
Total Value
$30.88K
Shares Held After
1,545,620
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LEXICON PHARMACEUTICALS, INC.
(LXRX)
DEBBANE RAYMOND
— Director
Feb 20, 2026
Purchase
Shares
100,000
Price
$1.48
Total Value
$147.79K
Shares Held After
1,804,186
% of Holdings
5.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSULET CORP
(PODD)
McEvoy Ashley
— Director
Feb 20, 2026
Purchase
Shares
4,300
Price
$239.35
Total Value
$1.03M
Shares Held After
13,916
% of Holdings
30.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RAPID MICRO BIOSYSTEMS, INC.
(RPID)
WIRTJES SEAN M
— CHIEF FINANCIAL OFFICER
Feb 20, 2026
Sale
Shares
17,254
Price
$3.92
Total Value
$67.69K
Shares Held After
563,674
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RAPID MICRO BIOSYSTEMS, INC.
(RPID)
Wilson John J. Addington
— CHIEF OPERATING OFFICER
Feb 20, 2026
Sale
Shares
5,403
Price
$3.92
Total Value
$21.20K
Shares Held After
326,365
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
Polovin Andrew
— EVP, Chief Legal Officer
Feb 20, 2026
Sale
Shares
100
Price
$60.97
Total Value
$6.10K
Shares Held After
126,918
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
Polovin Andrew
— EVP, Chief Legal Officer
Feb 20, 2026
Sale
Shares
10,849
Price
$60.30
Total Value
$654.19K
Shares Held After
127,018
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ENSIGN GROUP, INC
(ENSG)
Uychiat Pison Marivic
— Director
Feb 20, 2026
Sale
Shares
67
Price
$204.92
Total Value
$13.73K
Shares Held After
14,340
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Pavlov George
— Director
Feb 20, 2026
Purchase
Shares
9,920
Price
$17.86
Total Value
$177.17K
Shares Held After
25,000
% of Holdings
39.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Esposito Pamela
— Director
Feb 20, 2026
Sale
Shares
600
Price
$88.10
Total Value
$52.86K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Esposito Pamela
— Director
Feb 20, 2026
Sale
Shares
1,900
Price
$87.06
Total Value
$165.41K
Shares Held After
600
% of Holdings
76.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
13,587
Price
$59.05
Total Value
$802.31K
Shares Held After
1,989,626
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
3,716
Price
$59.70
Total Value
$221.85K
Shares Held After
15,922,469
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
95,567
Price
$59.04
Total Value
$5.64M
Shares Held After
15,926,185
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
33,717
Price
$58.31
Total Value
$1.97M
Shares Held After
16,021,752
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
923
Price
$59.70
Total Value
$55.10K
Shares Held After
8,908,283
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
23,775
Price
$59.04
Total Value
$1.40M
Shares Held After
8,909,206
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
LEFKOFSKY ERIC P
— Director
Feb 19, 2026
Sale
Shares
8,552
Price
$58.31
Total Value
$498.67K
Shares Held After
8,932,981
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Roivant Sciences Ltd.
(ROIV)
Torti Frank
— President and Vant Chair
Feb 19, 2026
Sale
Shares
1,400,000
Price
$27.42
Total Value
$38.39M
Shares Held After
13,736,547
% of Holdings
9.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Avantor, Inc.
(AVTR)
LUCIER GREGORY T
— Director
Feb 19, 2026
Purchase
Shares
50,000
Price
$9.16
Total Value
$458.00K
Shares Held After
50,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Feb 19, 2026
Sale
Shares
10,834
Price
$262.10
Total Value
$2.84M
Shares Held After
78,691
% of Holdings
12.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Feb 19, 2026
Sale
Shares
8,116
Price
$260.49
Total Value
$2.11M
Shares Held After
89,525
% of Holdings
8.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EXELIXIS, INC.
(EXEL)
Aftab Dana
— EVP, Research and Development
Feb 19, 2026
Sale
Shares
29,873
Price
$44.35
Total Value
$1.32M
Shares Held After
664,024
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Davis Krista
— SVP, CHIEF HR OFFICER
Feb 19, 2026
Sale
Shares
2,084
Price
$77.53
Total Value
$161.57K
Shares Held After
50,993
% of Holdings
3.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
Feb 19, 2026
Sale
Shares
590
Price
$69.82
Total Value
$41.19K
Shares Held After
105,212
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
Feb 19, 2026
Sale
Shares
212
Price
$68.54
Total Value
$14.53K
Shares Held After
105,802
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
Feb 19, 2026
Sale
Shares
1,629
Price
$69.82
Total Value
$113.74K
Shares Held After
106,014
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
Feb 19, 2026
Sale
Shares
588
Price
$68.54
Total Value
$40.30K
Shares Held After
107,643
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
WEISNER AIMEE S
— Director
Feb 19, 2026
Sale
Shares
6,471
Price
$118.56
Total Value
$767.20K
Shares Held After
18,806
% of Holdings
25.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
WEISNER AIMEE S
— Director
Feb 19, 2026
Sale
Shares
1,134
Price
$117.33
Total Value
$133.05K
Shares Held After
25,277
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
WEISNER AIMEE S
— Director
Feb 19, 2026
Sale
Shares
5,242
Price
$116.64
Total Value
$611.43K
Shares Held After
26,411
% of Holdings
16.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
WEISNER AIMEE S
— Director
Feb 19, 2026
Sale
Shares
2,153
Price
$115.69
Total Value
$249.08K
Shares Held After
31,653
% of Holdings
6.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SUPERNUS PHARMACEUTICALS, INC.
(SUPN)
Sensenig Bethany
— Director
Feb 19, 2026
Sale
Shares
3,258
Price
$51.27
Total Value
$167.04K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SUPERNUS PHARMACEUTICALS, INC.
(SUPN)
Sensenig Bethany
— Director
Feb 19, 2026
Sale
Shares
1,217
Price
$50.31
Total Value
$61.23K
Shares Held After
3,258
% of Holdings
27.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Feb 19, 2026
Sale
Shares
1,030
Price
$153.38
Total Value
$157.98K
Shares Held After
301,185
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Feb 19, 2026
Sale
Shares
2,377
Price
$151.92
Total Value
$361.11K
Shares Held After
302,215
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Feb 19, 2026
Sale
Shares
3,413
Price
$151.12
Total Value
$515.77K
Shares Held After
304,592
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Feb 19, 2026
Sale
Shares
1,891
Price
$150.10
Total Value
$283.84K
Shares Held After
308,005
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Feb 19, 2026
Sale
Shares
1,988
Price
$149.17
Total Value
$296.55K
Shares Held After
309,896
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 19, 2026
Sale
Shares
602
Price
$72.80
Total Value
$43.83K
Shares Held After
234,451
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 19, 2026
Sale
Shares
8,528
Price
$72.08
Total Value
$614.70K
Shares Held After
235,053
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 19, 2026
Sale
Shares
18,923
Price
$71.03
Total Value
$1.34M
Shares Held After
243,581
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Zoghbi Huda Y
— Director
Feb 19, 2026
Sale
Shares
4
Price
$790.00
Total Value
$3.16K
Shares Held After
1,703
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Zoghbi Huda Y
— Director
Feb 19, 2026
Sale
Shares
56
Price
$785.61
Total Value
$43.99K
Shares Held After
1,707
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Zoghbi Huda Y
— Director
Feb 19, 2026
Sale
Shares
160
Price
$784.45
Total Value
$125.51K
Shares Held After
1,763
% of Holdings
8.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Zoghbi Huda Y
— Director
Feb 19, 2026
Sale
Shares
220
Price
$783.29
Total Value
$172.32K
Shares Held After
1,923
% of Holdings
10.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 2251–2300 of 5391 transactions (page 46 of 108)
Version: v26.3.33